Providers’ use of pharmacogenetic testing to inform opioid prescribing among veterans
- 1 September 2024
- journal article
- research article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 25 (12-13) , 495-501
Abstract
Aim: To survey Veterans Health Administration providers who prescribed tramadol or codeine to patients with known genotyping for cytochrome 2D6 (CYP2D6) to ascertain awareness of their patient's pharmacogenetic (PGx) test status, whether these results influenced prescribing, perceived benefit of PGx testing, and resources needed to obtain and deliver PGx testing information. Materials & methods: A provider survey was conducted of those who prescribed tramadol or codeine in a patient genotyped for CYP2D6. Results: Of 876 eligible providers, 220 completed the survey. Ten percent were aware that their patient received a PGx test, 64% had not ordered any PGx test related to any medication in the prior year, 55% strongly agreed or agreed that PGx testing is or will be valuable to guide pain medication prescriptions, 29% felt that the evidence base for PGx testing is very strong or moderately strong, 22% responded likely or extremely likely to order a future PGx test, and 51% felt that it would be either very important or fairly important to have a local subject matter expert as a resource for PGx testing. Conclusion: There are modifiable factors that the Veterans Health Administration could address to optimize PGx testing for pain management.Keywords
This publication has 23 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid TherapyClinical Pharmacology & Therapeutics, 2021
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled studyJournal of Psychiatric Research, 2019
- Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Genetics in Medicine, 2017
- Pharmacogenomics in the clinicNature, 2015
- Parsing interindividual drug variability: an emerging role for systems pharmacologyWIREs Mechanisms of Disease, 2015
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variationPharmacology & Therapeutics, 2013
- A Review of Pharmacogenetics of Adverse Drug Reactions in Elderly PeopleDrug Safety, 2012
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Genetic susceptibility to adverse drug reactionsTrends in Pharmacological Sciences, 2001